Advertisement
Screener

Immune Design Corp. Operating Cash Flow

Immune Design Corp. Operating Cash Flow

Immune Design Corp. reported Operating Cash Flow of -$40.27 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2018-11-06

  • Immune Design Corp. net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$12.97M.
  • Immune Design Corp. net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$10.92M.
  • Immune Design Corp. net cash provided by (used in) operating activities for the quarter ending 2018-03-31 was -$16.38M.
  • Immune Design Corp. net cash provided by (used in) operating activities for the quarter ending 2017-09-30 was -$17.18M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filed
2018-09-30-$12.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$23.89M
derived: sum of 2 quarters · filed 2018-11-06
-$40.27M
10-Q · filed 2018-11-06
2018-06-30-$10.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
-$27.30M
10-Q · filed 2018-08-01
2018-03-31-$16.38M
10-Q · filed 2018-05-03
2017-09-30-$17.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$25.84M
derived: sum of 2 quarters · filed 2018-11-06
-$37.02M
10-Q · filed 2018-11-06
-$43.22M
10-Q · filed 2017-11-01
2017-06-30-$8.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
-$19.84M
10-Q · filed 2018-08-01
-$26.04M
10-Q · filed 2017-08-02
2017-03-31-$11.18M
10-Q · filed 2018-05-03
2016-09-30-$10.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$31.36M
10-Q · filed 2017-11-01
2016-06-30-$20.44M
10-Q · filed 2017-08-02